The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Related News Articles

Chairperson's File
Public
One of the most rewarding parts of being an AHA member and serving on the board is building relationships with other leaders who share a passion for making…
Headline
AHA President and CEO Rick Pollack today announced his plans to retire by the end of 2026. A 43-year veteran of the association, Pollack has served as its…
Chairperson's File
Public
When I began my year as AHA Board Chair, my goal was for us to be all in. In a year that was full of many tests — OBBBA, executive orders and an ongoing,…
Headline
Thomas Lee, M.D., chief medical officer of Press Ganey and editor-in-chief of NEJM Catalyst, explores why social capital is becoming the most critical asset in…
Headline
The AHA announced Nov. 12 that Pete November, president and CEO of Ochsner Health in Louisiana, will fill a vacancy on its Board of Trustees effective Jan. 1,…
Blog
Public
The Advanced Practice Provider (APP) Leadership Advisory Group began as a grassroots conversation — APPs and AHA representatives recognizing that traditional…